Skip to main content
. 2020 Nov 10;324(18):1–9. doi: 10.1001/jama.2020.19181

Table 2. Changes in Volume and Case Mix.

BPCI Matched controls Adjusted differential change in case mix, difference in differences (95% CI)a
Baseline period Intervention period Unadjusted difference Baseline period Intervention period Unadjusted difference
No. of SNFs 448 448 1958 1958
No. of beneficiaries 5075 11 762 20 509 43 302
No. of episodes 5556 13 314 22 562 49 443
Quarterly discharges per SNF, mean (SD) 4.1 (5.4) 2.1 (4.4) −2.0 3.8 (5.8) 1.8 (4.1) −2.0 0.0 (−0.3 to 0.4)
Patient characteristics, %
Age, y
≤64 6.2 6.2 0.0 6.5 6.0 −0.5 0.5 (−0.5 to 1.4)
65-79 51.1 50.4 −0.7 50.4 49.5 −0.9 0.2 (−1.9 to 2.3)
≥80 42.7 43.4 0.7 43.1 44.5 1.3 −0.7 (−2.7 to 1.4)
Men 28.3 27.6 −0.7 26.8 28.0 1.2 −1.9 (−3.5 to −0.3)
Women 71.7 72.4 0.7 73.2 72.0 −1.2 1.9 (0.3 to 3.5)
Medicaid dual eligible 16.9 16.6 −0.3 17.5 17.3 −0.3 0.0 (−1.8 to 1.8)
Disabled without end-stage kidney disease 16.2 16.8 0.6 15.7 16.4 0.7 −0.1 (−1.5 to 1.4)
Frailb 9.4 10.4 1.0 9.7 10.8 1.1 −0.06 (−1.41 to 1.29)
Dementiac 4.3 4.4 0.0 5.2 4.4 −0.8 0.8 (0.0 to 1.62)
No. of chronic conditionsd 5.0 5.1 0.1 5.0 5.1 0.1 0.00 (−0.12 to 0.12)
Race/ethnicity
White 89.0 88.8 −0.2 90.0 89.6 −0.4 0.2 (−1.3 to 1.6)
Black 7.3 7.2 −0.2 5.8 6.1 0.2 −0.4 (−1.6 to 0.8)
Hispanic 1.0 0.9 0.0 1.4 1.3 −0.1 0.1 (−0.4 to 0.5)
Unknown or othere 2.7 3.2 0.5 2.8 3.1 0.3 0.2 (−0.4 to 0.8)
Level of complexity, %f
DRG without complications or comorbiditiesf 91.7 90.0 −1.7 91.6 89.7 −1.9 0.21 (−0.9 to 1.3)
DRG with major complications or comorbiditiesg 8.3 10.0 1.7 8.4 10.3 1.9 −0.21 (−1.3 to 0.9)

Abbreviations: BPCI, Bundled Payment for Care Improvement; DRG, diagnosis-related group; LEJR, lower extremity joint replacement; SNF, skilled nursing facility.

a

Adjusted estimates show the differential change in the proportion of patient characteristics between treatment and control groups after vs before BPCI implementation. All estimates use standard errors clustered at the SNF level. The differential change estimates can be interpreted as the average within-SNF change attributable to BPCI implementation.

b

Frailty was defined using a previously validated claims-based frailty index from Kim et al.21,22 Patients in the top 10% of the frailty index over the entire population of SNF admissions were classified as frail.

c

Dementia was defined using International Classification of Diseases-Ninth Revision codes described in Goodman et al.23 Patients with not otherwise-specified dementia diagnoses were included because routine use of nonspecific diagnostic codes is common, such that excluding them would result in omission of many affected individuals.

d

The presence of 27 conditions was gathered from the Chronic Condition Data Warehouse, which uses claims since 1999 to describe Medicare beneficiaries’ accumulated chronic disease burden. Chronic conditions were defined as any condition present by the end of the calendar year prior to the LEJR episode. Conditions included Alzheimer disease, Alzheimer disease and related disorders or senile dementia, anemia, asthma, atrial fibrillation, benign prostatic hyperplasia, breast cancer, cataract, chronic kidney disease, chronic obstructive pulmonary disease, colorectal cancer, depression, diabetes, endometrial cancer, glaucoma, heart failure, hip or pelvic fracture, hyperlipidemia, hypertension, hypothyroidism, ischemic heart disease, lung cancer, osteoporosis, prostate cancer, acute myocardial infarction, rheumatoid arthritis, and stroke or transient ischemic attack.

e

The category of Other includes American Indian or Alaska Native, Asian, Native Hawaiian or Pacific Islander, these are the options for self-identified race/ethnicity in the Medicare enrollment file besides White and Black race or Hispanic/Latino. Less than 1% of beneficiaries are coded as unknown race.

f

Without complications or comorbidities refers to DRG 470 (LEJR without major complications or coexisting conditions).

g

With major complications or comorbidities refers to DRG 469 (LEJR with major complications or coexisting comorbidities).